EP2830626
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.3.2013:
2.1.2019:
13712589.4
:
28.3.2033
:
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
29.3.2013
2.1.2019
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
KNEISSEL, Michaela:
Basel, CH
:
GUAGNANO, Vito:
Basel, CH
:
GRAUS PORTA, Diana:
Basel, CH
:
WÖHRLE, Simon:
Freiburg, DE
:
201261617889 P:
30.3.2012:
US
:
EP2013056811:
29.3.2013
:
A61P 3/12, A61P 19/08, A61K 38/17, A61K 38/29, A61K 45/06, A61K 31/59, A61K 33/06, A61K 33/42, A61K 31/506